Seller record · Telehealth service

BetterMe Rx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the treatment pages, the answers page or the safety information pages.

At a glance

BetterMe RxTelehealth service

7/8criteria passed

Price: Semaglutide injection from $145 a month, tirzepatide injection from $185
Sells: compounded semaglutide injection (with glycine), and 10 more
FDA letters: None on file

Visit BetterMe Rx See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide as weekly injections or daily tablets, a microdosing program, NAD+ and sermorelin. Care runs through outside physician networks, and its answers page names seven partner pharmacies with their addresses.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms, in the privacy policy or in the telehealth consent; the terms name only BetterMe Rx as the operator.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	BetterMe Rx's FAQ; BetterMe Rx's weight loss page
S2	Prescription gating	PASS	BetterMe Rx's FAQ; BetterMe Rx's GLP-1 lander page
S3	Pharmacy identification	PASS	BetterMe Rx's FAQ
S4	Compounding disclosure	PASS	BetterMe Rx's weight loss page; BetterMe Rx's important safety information injectable semaglutide page
S5	Analytical documentation	FAIL	BetterMe Rx's weight loss page; BetterMe Rx's FAQ
S6	Business address	PASS	BetterMe Rx's contact page; BetterMe Rx's terms of use page; BetterMe Rx's returns refund policy
S7	Price disclosure	PASS	BetterMe Rx's GLP-1 lander page; BetterMe Rx's weight loss direct sale lander page; BetterMe Rx's weight loss page; BetterMe Rx's FAQ; BetterMe Rx's HRT page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSUS-based doctors review each patient's answers and prescribe only as necessary, and the weight loss page says a licensed provider always reviews before prescribing. The answers page names Telegra MD and Dr Telx as its provider networks.Source: BetterMe Rx's FAQ; BetterMe Rx's weight loss page.

S2PASSThe answers page says a visit starts with a brief set of medical questions that US-based doctors review before prescribing, and that medication is billed when it ships. A GLP-1 landing page says no medication charge is made if the prescription is not approved.Source: BetterMe Rx's FAQ; BetterMe Rx's GLP-1 lander page.

S3PASSThe answers page lists seven current pharmacy partners with street addresses: EpiqScripts in Richardson, Texas, Valiant RX in Ypsilanti, Michigan, GoGoMeds at 525 Alexandria Pike, Southgate, Kentucky, The Pharmacy Hub in Miami, Florida, Emerald Compounding Pharmacy at 5325 Primrose Lake Circle, Tampa, Florida, Striker in Katy, Texas, and Belmar Pharmacy at 2500 Lakepointe Parkway, Odessa, Florida.Source: BetterMe Rx's FAQ.

S4PASSThe weight loss page labels both injections as compounded, and the safety information page for the semaglutide injection says it is a compounded medication, custom-prepared and not FDA-approved, and not affiliated with the maker of Wegovy or Ozempic.Source: BetterMe Rx's weight loss page; BetterMe Rx's important safety information injectable semaglutide page.

S5FAILNo certificate of analysis or lot document is published on the treatment pages, the answers page or the safety information pages.Source: BetterMe Rx's weight loss page; BetterMe Rx's FAQ.

S6PASS320 Gold Ave. SW, Ste 620, PMB 2281, Albuquerque, NM 87102, a private mailbox, printed on the contact page and in the terms and the privacy policy. Returns go to 21250 Hawthorne Blvd, Ste 160-C, Torrance, CA 90503.Source: BetterMe Rx's contact page; BetterMe Rx's terms of use page; BetterMe Rx's returns refund policy.

S7PASSNo price is printed on the weight loss, microdosing, NAD+ or sermorelin pages, and the answers page says the cost is shown once therapy is found appropriate. The brand's own GLP-1 landing pages print two sets of prices. One offers limited-time intro pricing against a regular price: semaglutide injection $199 a month against $279, tirzepatide injection $249 against $379, oral semaglutide $250 against $299 and oral tirzepatide $265 against $399, as low as $99, $159, $185 and $215 a month on a 12-month plan. Another prints semaglutide injection starting at $145 a month, tirzepatide injection at $185 and either tablet at $215. The hormone page prints an estrogen cream at $179 a month.Source: BetterMe Rx's GLP-1 lander page; BetterMe Rx's weight loss direct sale lander page; BetterMe Rx's weight loss page; BetterMe Rx's FAQ; BetterMe Rx's HRT page.

S8PASSNo FDA warning letter names BetterMe Rx, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection (with glycine), compounded tirzepatide injection (with glycine), compounded oral semaglutide tablet, compounded oral tirzepatide tablet, microdose compounded semaglutide and tirzepatide, injectable NAD+, NAD+ nasal spray, injectable sermorelin, sermorelin oral tablet, estrogen HRT cream, erectile dysfunction treatments.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+

Visit BetterMe Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.